BIOMAT Database Logo BIOMAT Database Logo

Spironolactone and potassium canrenoate metabolism. 1985

P Gardiner

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D002191 Canrenoic Acid A synthetic pregnadiene derivative with anti-aldosterone activity. Canrenoate Potassium,Potassium Canrenoate,17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic Acid,Kalium-Can.-Ratiopharm,SC-14266,Soldactone,Soludactone,Spiroctan,17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid,Acid, 17-Hydroxy-3-Oxo-17alpha-Pregna-4,6-Diene-21-Carboxylic,Acid, Canrenoic,Canrenoate, Potassium,Kalium Can. Ratiopharm,SC 14266,SC14266
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013148 Spironolactone A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) Spirolactone,Aldactone,Aldactone A,Aquareduct,Duraspiron,Espironolactona Alter,Espironolactona Mundogen,Flumach,Frumikal,Jenaspiron,Novo-Spiroton,Practon,SC-9420,Spiractin,Spiro L.U.T.,Spiro Von Ct,Spirobeta,Spirogamma,Spirolang,Spirono-Isis,Spironone,Spirospare,Veroshpiron,Verospiron,Verospirone,Ct, Spiro Von,Novo Spiroton,NovoSpiroton,SC 9420,SC9420,Spirono Isis,Von Ct, Spiro

Related Publications

P Gardiner
[Action of spironolactone and potassium canrenoate].
December 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
P Gardiner
Gynaecomastia after spironolactone and potassium canrenoate.
March 1986, Lancet (London, England),
P Gardiner
Spironolactone and potassium canrenoate in normal man.
August 1976, Clinical pharmacology and therapeutics,
P Gardiner
Pharmacokinetics of spironolactone and potassium canrenoate in humans.
March 1985, Journal of pharmacobio-dynamics,
P Gardiner
Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: mutagenic metabolites unique to potassium canrenoate.
January 1988, Archives of toxicology,
P Gardiner
Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
P Gardiner
Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
September 1985, Lancet (London, England),
P Gardiner
Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.
January 1974, European journal of clinical pharmacology,
P Gardiner
Lymphocyte function tests in cirrhotic patients under treatment with spironolactone and potassium canrenoate.
January 1988, The Journal of international medical research,
P Gardiner
Spironolactone and canrenoate: different antialdosteronic diuretic agents.
May 1991, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!